Smith & Nephew PLC (SN.L) Stock Forecast
LSE · Healthcare
Current price
£11.46
Market cap
£9.70B
Mean price target
£14.02
Implied upside
22.4%
Key takeaways
- Analysts rate Smith & Nephew PLC a “Buy”, with a mean price target of £14.02 — about 22.4% upside from the current £11.46, based on 17 analysts.
- SN.L is trading in the middle of its 52-week range, at 25% of the £10.50–£14.41 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 17 |
| Mean target | £14.02 |
| High target | £16.38 |
| Low target | £12.08 |
| Rating split (SB / B / H / S / SS) | 2 / 5 / 11 / 0 / 0 |
Price & trading
| Current price | £11.46 |
|---|---|
| Previous close | £11.53 |
| 52-week high | £14.41 |
| 52-week low | £10.50 |
| 50-day average | £11.42 |
| Beta | 0.67 |
See the full SN.L breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Smith & Nephew PLC (SN.L) share price?
- Smith & Nephew PLC last traded at £11.46 with a market capitalisation of about £9.7B.
- What is the analyst price target for SN.L?
- The mean analyst price target for Smith & Nephew PLC is £14.02, roughly 22.4% above the latest price. The current consensus rating is “Buy”.
- Where can I see Smith & Nephew PLC's full financial metrics?
- Luminoso tracks SN.L's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.